Innovita Biological Technology Co., Ltd. Stock: price and insider trades · China
英诺特
Innovita Biological Technology Co., Ltd.: what insiders have been doing
Insider filings for Innovita Biological Technology Co., Ltd. are scarce in the SSE / SZSE (CSRC) feed, the latest one published on 3 November 2025. This page will fill in as new trades are disclosed. This summary is built from SSE / SZSE (CSRC) disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleAnalyst consensus: bullish or bearish?
Analysts rate Innovita Biological Technology Co., Ltd. Strong Buy (bullish), based on 1 analysts. Average price target: CN¥53.81.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 5,240 shares100.0% of flowA股XSHGSSE:173000009708934340
1 of 1 declaration
About Innovita Biological Technology Co., Ltd.
英诺特 is a company operating in the healthcare and pharmaceutical sector, listed on the XSHG market. It specializes in the development and commercialization of innovative pharmaceutical products.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
